SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001697884-22-000006
Filing Date
2022-05-03
Accepted
2022-05-03 06:22:28
Documents
48
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 vsbc10k_2022.htm   iXBRL 10-K 626368
2 exhibit31_1.htm EX-31.1 9204
3 exhibit31_2.htm EX-31.2 8819
4 exhibit32_1.htm EX-32.1 4923
5 exhibit32_2.htm EX-32.2 4933
6 image_001.jpg GRAPHIC 30120
7 image_002.jpg GRAPHIC 47931
8 image_003.jpg GRAPHIC 3634
  Complete submission text file 0001697884-22-000006.txt   2698245

Data Files

Seq Description Document Type Size
9 vsbc-20220131.xsd EX-101.SCH 14117
10 vsbc-20220131_cal.xml EX-101.CAL 18569
11 vsbc-20220131_def.xml EX-101.DEF 22801
12 vsbc-20220131_lab.xml EX-101.LAB 160051
13 vsbc-20220131_pre.xml EX-101.PRE 117223
42 EXTRACTED XBRL INSTANCE DOCUMENT vsbc10k_2022_htm.xml XML 255747
Mailing Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618 9492029235
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

IRS No.: 371836726 | Fiscal Year End: 0131
Type: 10-K | Act: 34 | File No.: 333-216465 | Film No.: 22884504
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services